Bone densitometry vendor Lunar last month announced that its third-quarter revenues would likely decline compared with the same quarter last year. Lunar of Madison, WI, pointed to below-average sales of densitometers in the U.S. and Asia as a reason for
Bone densitometry vendor Lunar last month announced that its third-quarter revenues would likely decline compared with the same quarter last year. Lunar of Madison, WI, pointed to below-average sales of densitometers in the U.S. and Asia as a reason for the anticipated down quarter (end-March 31).
While the company attributed the dip in Asian sales to the region's recent currency difficulties, U.S. demand has been shifting away from traditional hospital markets toward lower priced systems for physician offices. In an effort to improve access to these emerging markets, Lunar is implementing new distribution channels. The company expects to soon announce new national distributor relationships for its existing physician-office products, as well as its Achilles ultrasound densitometer, which is pending Food and Drug Administration premarket approval.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.